US · Healthcare

Aion Therapeutic Inc (ANTCF)

Drug Manufacturers - Specialty & Generic

Aion Therapeutic Inc (ANTCF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ANTCF

P/E ratio

18.00

Aion Therapeutic Inc (ANTCF) — FAQ

What is ANTCF's P/E ratio?

The price-to-earnings (P/E) ratio for Aion Therapeutic Inc (ANTCF) is 18.00 (data as of 2026-03-23).

Does Aion Therapeutic Inc pay a dividend?

Dividend yield is not available in the current snapshot for Aion Therapeutic Inc (ANTCF). Check the MyAverix Finance app for the latest dividend data.

What sector is Aion Therapeutic Inc in?

Aion Therapeutic Inc (ANTCF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is ANTCF listed on?

ANTCF is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)